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Audiogenic seizure-prone mice can be protected from seizure-associated death by exposure to an oxygen atmosphere or treatment with selective serotonergic reuptake inhibitors (SSRIs). We have shown previously in a
rat model that epileptic seizure activity can spread through brainstem areas to cause suﬃcient laryngospasm for
obstructive apnea and that the period of seizure-associated obstructive apnea can last long enough for respiratory arrest to occur.
We hypothesized that both the oxygen-rich atmosphere and SSRIs function by prolonging the time to respiratory arrest, thus ensuring that seizure activity stops before the point of respiratory arrest to allow recovery
of respiratory function. To test this hypothesis, we evaluated each preventative treatment in a rat model of
controlled airway occlusion where the times to respiratory arrest can be measured.
Adult male Sprague Dawley rats (median age = 66 days) were studied in the absence of any seizure activity.
By directly studying responses to controlled airway occlusion, rather than airway occlusion secondary to seizure
activity, we could isolate the eﬀects of manipulations that might prolong respiratory arrest from the eﬀects of
those manipulations on seizure intensity. All group sizes were ≥ 8 animals per group.
We found that both oxygen exposure and ﬂuoxetine signiﬁcantly increased the time to respiratory arrest by
up to 65% (p < .0001 for 5 min oxygen exposure; p = .031 for 25 mg/kg ﬂuoxetine tested 60 min after
injection) and, given that neither treatment has been shown to signiﬁcantly alter seizure duration, these increases can account for the protection of either manipulation against death in sudden death models. Importantly,
we found that 30 s of exposure to oxygen produced nearly the same protection as 5 min exposure suggesting that
oxygen exposure could start after a seizure starts (p = .0012 for 30 s oxygen exposure). Experiments with 50%
oxygen/50% air mixtures indicate that the oxygen concentration needs to be above about 60% to ensure that
times to respiratory arrest will always be longer than a period of seizure-induced airway occlusion. Selective
serotonin reuptake inhibitors, while instructive with regard to mechanism, require impractical dosing and may
carry additional risk in the form of greater challenges for resuscitation.
We conclude that oxygen exposure or SSRI treatment prevent seizure associated death by suﬃciently
prolonging the time to respiratory arrest so that respiratory function can recover after the seizure abates and
eliminates the stimulus for seizure-induced apnea.

1. Introduction
The growing body of clinical and preclinical research and clinical
evidence from cases of sudden death in epilepsy (SUDEP) and near miss

cases has led to more focused ideas about (1) the underlying mechanism
(s) and (2) potential biomarkers that may help to stratify risk (e.g.
(Devinsky et al., 2016; Jansen and Lagae, 2010; Lacuey et al., 2018; Poh
et al., 2012; Stewart et al., 2017; Vilella et al., 2018)).
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WEIGHT median = 306, mean = 330 g; Envigo Chicago, IL) were
housed in AAALAC-accredited facilities and maintained on a 12 h
light:dark cycle with an average temperature of 23 °C and humidity of
55%, monitored daily, and had unrestricted access to water and food.
Urethane (1.5 g/kg ip) was used for anesthesia in all animals.
Euthanasia at the end of experiments included overdosing animals with
mixture of pentobarbital (150 mg/kg) and phenytoin (19 mg/kg;
Euthasol, Virbac AH, Fort Worth, TX).

Although SUDEP is the most common cause of death among persons
with epilepsy (e.g. (Barot and Nei, 2019; Devinsky et al., 2016)), deaths
are thankfully rare. Most deaths occur at night when the individual is in
bed at home (e.g. (Clark and Riney, 2016; Massey et al., 2014; Purnell
et al., 2018; Ryvlin et al., 2013; Shorvon and Tomson, 2011)). The
rarity of events and their circumstances create most of the challenge for
collecting detailed physiological records during seizure events that
could be used to accelerate the search for mechanism and biomarkers.
Preclinical studies permit manipulations and monitoring that (1) can be
impossible to obtain from persons with epilepsy, and (2) can suggest
speciﬁc mechanistic features to focus clinical studies.
We have shown previously that epileptic seizure activity can spread
through lower brain areas to activate laryngomotor eﬀerent ﬁbers and
cause laryngospasm (i.e. not via reﬂex mechanisms). The laryngospasm
can be suﬃcient to completely obstruct the airway (obstructive apnea)
and that the period of obstructive apnea can last long enough for respiratory arrest to occur (Nakase et al., 2016; Stewart et al., 2017). Our
deﬁnition of respiratory arrest is the point at which the individual stops
attempting to draw a breath. We consider this to be equivalent to the
“onset” of terminal apnea as deﬁned by Ryvlin et al. (Ryvlin et al.,
2013).
Associated with the period of airway occlusion is a progressive
oxygen desaturation, and this loss of oxygen can contribute to seizure
termination (Hotta et al., 2009; Nakase et al., 2016; Stewart et al.,
2017). As the seizure ends, on its own or from hypoxia, it also ceases to
be a stimulus for laryngospasm, and the airway can open. If respiratory
arrest occurs before the airway reopens, the individual will progress
from respiratory arrest to cardiac arrest and death unless mechanically
resuscitated. If the airway reopens before respiratory arrest occurs, the
individual will spontaneously resume breathing and recover from the
event.
In mouse studies, DBA/2 mice experiencing audiogenic seizures that
would normally be fatal with nearly 100% mortality were protected by
experiencing those seizures in an oxygen atmosphere (Venit et al.,
2004; Willott and Henry, 1976). Similarly, selective serotonergic reuptake inhibitors (SSRIs) such as ﬂuoxetine or 5-HT2A agonists have
been shown to protect against death in multiple strains of audiogenic
seizure-prone mice (Buchanan et al., 2014; Faingold et al., 2014;
Faingold et al., 2011b; Zeng et al., 2015), suggesting that these drugs
protect the brainstem circuits critical for respiration (Bateman et al.,
2010; Blum, 2009; Buchanan et al., 2014; Faingold et al., 2014;
Faingold et al., 2011a; Feng and Faingold, 2017; Richerson and
Buchanan, 2011; Tupal and Faingold, 2006; Uteshev et al., 2010).
We hypothesized that both the oxygen-rich atmosphere and the
SSRIs function by prolonging the time to respiratory arrest, thus ensuring that seizure activity could stop on its own before the individual
was at risk for respiratory arrest. To test this hypothesis, we evaluated
each preventative treatment in a rat model of controlled airway occlusion that permits (1) controlled complete airway closure, (2) control
of the atmosphere available to the animal, and (3) continuous monitoring of physiological variables including airway pressures associated
with normal spontaneous breathing and attempts to breathe during
occlusion. This last element enables the precise determination of the
point of respiratory arrest. This direct measure of the impact of SSRIs on
the time to respiratory arrest would also be free from the confound of
the drugs' eﬀects on the intensity of seizure activity (Buchanan et al.,
2014).

2.1. Monitoring/recording
ECG recordings. Limb‑lead ECG was recorded using copper strips
coated with conductive gel wrapped around both forelimbs and either
the base of the tail or the left hindlimb. Signals were ampliﬁed and
ﬁltered to pass 1 Hz to 1 kHz (Model 1800 AC ampliﬁer with headstages; A-M Systems, Sequim, WA) and digitized at 2 kHz (Micro1401
controlled by Spike 2 software; Cambridge Electronic Design,
Cambridge, UK). Rhythm was assessed by reviewing P waves and associated QRS complexes for variations in wave shape, beat-to-beat intervals, and atrial-ventricular coupling.
Pulse oximetry. Arterial oxygen saturation was measured by using a
clip sensor on the thigh (TDR-43C, Med Associates, St Albans, VT)
coupled to a pulse oximeter (CANL-425SV-A, Med Assoc.). The raw
pulsatile waveform of the pulse oximeter was digitized (2 kHz) with
other signals.
Inspiratory airway pressures. A pressure transducer (CyQ, Columbus
Instruments, Columbus, OH) was connected to the sidearm of a Tshaped tracheal tube (see below). Inspiratory pressures during complete
airway occlusion were measured relative to those observed during
baseline breathing. Signals were digitized along with other signals recorded at the same time.
2.2. Other manipulations/implants
Tracheal implants. A T-shaped tracheal tube was placed through an
incision between cartilaginous rings of the trachea after the trachea was
exposed in the neck. The distal arm was “sealed” in the trachea with
suture around the trachea, compressing it against the outside wall of the
implant. The proximal arm was secured with suture to the outside of the
proximal trachea for additional mechanical stabilization.
Controlled airway occlusion. Obstructive apnea was produced with
controlled airway occlusion. The exterior arm in the straight path with
the implanted arm served breathing or could be occluded. A pressure
transducer on the tracheal tube sidearm recorded forces developed
during either normal breathing with the tracheal tube open to the atmosphere or during complete closure of the open port. In prior work,
we showed that during occlusion, respiratory eﬀort exerted to inspire
progressively increased with each attempt until eﬀort ceased and that
this point of respiratory arrest was associated with acute left ventricular
dilatation, hypokinesis, and asystole (Nakase et al., 2016). To control
the atmosphere available to the animal, the open port was connected to
a stream of air, oxygen, or an air/oxygen mixture that ﬂowed continuously past the open port and could be switched to control the
amount of time that the animal had access to a particular gas.
SSRI pretreatment. Animals were injected intraperitoneally with
ﬂuoxetine (25 mg/kg made as a 2 mg/ml solution in saline to ensure
complete solubilization) or with an equivalent volume of saline.
Injected volumes were 12.5 ml/kg and averaged 4.25 ± 1.00 ml/animal (mean ± standard deviation). Fluoxetine hydrochloride (cat#
1279804) was obtained from Sigma Aldrich Inc. (St. Louis, MO).

2. Materials and methods
Methods and implants were similar to those described in detail
previously (Mooney et al., 2019; Nakase et al., 2016; Villiere et al.,
2018). All procedures were approved by an Animal Care and Use
Committee and conducted in accordance with the United States Public
Health Service's Policy on Humane Care and Use of Laboratory Animals.
Adult male Sprague Dawley rats (AGE median = 66, mean = 88 days;

2.3. Experimental design
Oxygen-rich atmosphere exposure. Animals were randomly assigned to one of 4 groups: (1) exposure to an oxygen atmosphere for
5 min prior to airway occlusion, (2) exposure to an air stream for 5 min
2
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prior to airway occlusion, (3) switching to an oxygen stream for only
30 s prior to airway occlusion, or (4) switching to a mixed stream (50%
oxygen/50% air) for only 30 s prior to airway occlusion. Gas was
streamed at ~4 l/min. In all animals, the occlusion was left in place
until 10 s after the point of respiratory arrest, which was deﬁned as the
time of the peak of the last breath attempt. Each animal was resuscitated as described previously (Villiere et al., 2018), but only the
ﬁrst occlusion event in each animal was analyzed in this study (repeated occlusions change the response proﬁle to occlusion as described
in (Mooney et al., 2019)). Planned group sizes were 8 animals per
group.
SSRI pretreatment. Animals were randomly assigned to one of 2
groups: (1) systemic injection of ﬂuoxetine (25 mg/kg IP) 60 min prior
to occlusion testing, or (2) intraperitoneal saline of an equivalent volume based on animal weight 60 min prior to occlusion testing (e.g.
(Tupal and Faingold, 2006; Zeng et al., 2015)). Occlusion testing was
identical to that described for the oxygen exposed animals. Group sizes
were 8 animals per group.

exposure to 30 s of oxygen immediately prior to airway occlusion
(n = 10) increased the time to respiratory arrest by 52% (81.6 vs.
53.6 s) and the number of breath attempts (Fig. 2 E, F) was not signiﬁcantly diﬀerent from the results obtained with and exposure time of
5 min. A one-way ANOVA for the times to respiratory arrest was signiﬁcant (F (3, 34) = 9.972; p < .0001) and Dunnett's multiple comparisons of each oxygen group against air are shown in Fig. 2E. For the
numbers of breath attempts, a one-way ANOVA was also signiﬁcant (F
(3, 34) = 9.939; p < .0001) and Dunnett's multiple comparisons of
each oxygen group against air are shown in Fig. 2F. When the concentration of oxygen was reduced by mixing oxygen and air 1:1, and
applied for 30 s, the time to respiratory arrest trended to a higher value,
increasing by 24% (66.4 vs. 53.6 s) compared with air (n = 8 rats;
p > .05 after post-hoc correction for multiple comparisons, but
p = .014 in a straight comparison by t-test) and the number of breath
attempts was signiﬁcantly increased (Fig. 2F).

2.4. Data analysis and statistics

The results of experiments on animals receiving either ﬂuoxetine or
saline are shown in Fig. 3. Raw data examples are not shown because
the raw data closely resemble the raw data illustrated in Fig. 1, with
modest increases in the time to respiratory arrest. Fluoxetine delivered
intraperitoneally and evaluated at 1 h post-injection produced an
average increase in the time to respiratory arrest of 28% (63.8 vs.
49.9 s, n = 8, 8), but the number of breath attempts was almost
identical for the two groups (Fig. 3D), indicating a lower rate of attempts to inspire in the SSRI-treated animals.
When we evaluated the impact of systemic ﬂuoxetine on the preocclusion respiratory rate, we found that the largest eﬀect sizes for
ﬂuoxetine was on altering the rate of breathing (Fig. 3E, F). Two-way
ANOVA was signiﬁcant for ﬂuoxetine/saline (F (2, 28) = 283.5;
p < .0001), pre-injection/post-injection/occlusion (F (1, 14) = 30.20;
p < .0001), or the product of drug X condition (F (2, 28) = 9.536;
p = .0007). The corrected p values for multiple comparisons (Tukey)
are shown in Fig. 3E. Tracheal pressure measures do not give information on tidal volumes. SSRI treatment was shown to not alter
ventilation in DBA/1 mice (Zeng et al., 2015).
The respiratory rate was signiﬁcantly slowed by ﬂuoxetine. The
large rate diﬀerential between pre-injection and pre-occlusion (Fig. 3E,
F) suggest that ﬂuoxetine did impact the respiratory brainstem as
suggested by others (e.g. (Bateman et al., 2010; Blum, 2009; Devinsky
et al., 2016; Faingold et al., 2011b; Feng and Faingold, 2017; Massey
et al., 2014; Richerson and Buchanan, 2011; Tupal and Faingold, 2006;
Zeng et al., 2015)). The rate of breath attempts during occlusion was
lower than the pre-occlusion rate of actual respiration, but the magnitude occlusion-associated drops were similar between the saline and
ﬂuoxetine-treated animals. This lower rate of breath attempts during
occlusion did not signiﬁcantly alter the rate of desaturation, nor was
there any measurable eﬀect on the magnitudes of tracheal pressure
changes during inspiration attempts. Also observed was a tendency for
lower minimum oxygen saturation levels after SSRI treatment, but
average oxygen saturation minima were not statistically diﬀerent (34%
for ﬂuoxetine group, 37% for saline group).
Interestingly, and consistent with the tendency for lower minimum
oxygen saturation levels after SSRI treatment, it was more diﬃcult to
resuscitate animals in the SSRI group after respiratory arrest. We resuscitated animals with bolus gas delivery for lung inﬂation as described previously (Villiere et al., 2018). SSRI-treated animals required
more attempts on average than saline treated animals to eﬀect resuscitation (2.00 ± 0.76 vs. 0.50 ± 0.53 ﬁve milliliter air bolus
treatments for resuscitation; mean ± standard deviation; p = .0004).
All SSRI-treated animals required lung inﬂation for resuscitation,
whereas 4/8 saline treated animals spontaneously restarted breathing
after the occlusion was stopped (occlusion was stopped 10 s after the
point of respiratory arrest to conﬁrm that respiratory arrest had

3.2. SSRI pretreatment

Analyses were done with Spike 2 software (Cambridge Electronic
Design, Ltd., Cambridge, England) and Microsoft Excel. Data are reported as means ± standard deviation in the text and ﬁgures unless
otherwise noted. All statistics were computed with GraphPad Prism 8
software or IBM SPSS Statistics (version 24). Independent samples ttests, one-way and two-way analyses of variance were used for group
comparisons. A p < .05 was predeﬁned, after appropriate post-hoc
correction for multiple comparisons where appropriate, to be statistically signiﬁcant. The speciﬁc tests and post-hoc corrections are given in
the text with the results and in the ﬁgure legends.
3. Results
Fifty-four adult male animals were used. Thirty-eight was the ﬁnal
number of animals in the oxygen atmosphere series and 16 animals
were used in the SSRI series.
3.1. Oxygen-rich atmosphere exposure
Exposure to an oxygen-rich atmosphere prior to airway occlusion
prolonged the time to respiratory arrest. Examples of individual experiments on animals exposed to either an air stream or an oxygen
stream for 5 min prior to airway occlusion are shown in Fig. 1 and
multiple measures are summarized in Fig. 2. Key features of the responses are (1) a signiﬁcantly longer time to respiratory arrest in animals exposed to oxygen, (2) ECG changes indicative of hypoxia (ST
segment elevation, rate decreases due to missed QRS complexes, premature ventricular beats) preceding the point of respiratory arrest in all
animals, (3) a pattern of inspiratory attempts with rapidly increasing
eﬀort as the animal approaches the point of respiratory arrest in all
animals, and (4) minimum pulse oximetry levels that were comparable
across all groups (37% ± 11 for oxygen animals, n = 12, 30% ± 9 for
air animals, n = 8; mean, standard deviation). Interestingly, the breath
attempts made during the ﬁrst half of the occlusion period during
oxygen exposure show an initial stable pattern of moderate eﬀort that
transitioned into the pattern of increasing eﬀort seen during occlusions
in air (Fig. 1, tracheal pressure traces). Even clearer is the sustained
high level of oxygen saturation in the oxygen-breathing rat that persists
for about 30 s before the gradual decline with similar slope and endpoint to the air-breathing rat (Fig. 1, pulse oximetry traces). Speciﬁc
additional comparisons are illustrated in Fig. 2.
Whereas oxygen exposure for 5 min prior to airway occlusion led to
a 65% increase in the time to respiratory arrest (88.4 vs. 53.6 s), we
assessed shorter oxygen exposures (30 s) and short exposures to more
modest enrichment (50% oxygen/50% air for 30 s). As shown in Fig. 2,
3
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Fig. 1. Examples of prolongation of the time to respiratory arrest from oxygen exposure. Panel A: Controlled airway occlusion after breathing oxygen for 5 min. Time
of occlusion is marked by a heavy horizontal line. Last breath attempt (i.e. the point of respiratory arrest) occurred at 100 s after occlusion onset (marked by arrow).
Top trace shows limb lead ECG with initial normal sinus rhythm that showed signiﬁcant ST segment elevation indicative of hypoxic changes in the heart, bradycardia,
and premature ventricular contractions starting at about 80 s post-occlusion. The forces associated with breath attempts during airway occlusion are shown in the
center trace, and the pulse oximeter output is shown in the bottom trace of the panel. One hundred percent oxygen saturation is marked by the arrowhead at the right
edge of the panel and coincides with the bottom of the horizontal bar marking the period of occlusion. Panel B: Similar to panel A, but from an animal that was
breathing air. Note the signiﬁcantly shorter time to respiratory arrest (53 s) and shorter times to signiﬁcant cardiac rhythm irregularities (about 40 s). Panel C: Higher
temporal resolution illustrations of ST changes in the ECG from panels A and B during pre-occlusion and occlusion phases of the study. Times are marked in panel A
as C1 (pre-occlusion) and C2 (occlusion) and in panel B as C3 (pre-occlusion) and C4 (occlusion). Each segment in 0.5 s in duration.

Importantly, we found that 30 s of exposure to oxygen just prior to
airway occlusion produced nearly the equivalent protection as 5 min
exposure up to the point of occlusion, suggesting that oxygen exposure
could start after a seizure starts. Experiments with 50% oxygen/50% air
mixtures indicate that the concentration needs to be above about 60%
(the result of mixing equal quantities of pure oxygen with air) to ensure
times to respiratory arrest that are suﬃciently long that they will always be longer than the seizure and any period of seizure-induced
airway occlusion.
Selective serotonin reuptake inhibitors, while instructive with regard to mechanism require impractical dosing and carry additional risk
in the form of greater challenges for resuscitation.

occurred).

4. Discussion
We used a rat model in which obstructive apnea was caused with
controlled airway occlusion to evaluate two interventions that have
been shown to prevent death in animal models of sudden death in
epilepsy. We determined the times to respiratory arrest in animals
breathing oxygen vs. air, and animals treated with the selective serotonin receptor uptake inhibitor, ﬂuoxetine. We found that both oxygen
exposure and ﬂuoxetine signiﬁcantly increased the time to respiratory
arrest and, given that neither has been shown to alter seizure duration,
these increases can account for the protection of either manipulation
against death in sudden death models.
4
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(caption on next page)

5. Apnea and respiratory arrest

evident (e.g. (Nakase et al., 2016; Stewart et al., 2017)). In mice experiencing audiogenic seizures, however, death is associated with intense tonic convulsive activity marked by hindlimb extension that can
easily mask or prevent attempts to inspire during obstructive apnea.
Diﬀerentiating between central and obstructive forms of apnea in such
circumstances may not be possible with observation, plethysmography,

The discrimination between central and obstructive apnea can be
challenging without clear evidence of attempts or the lack of attempts
to breathe. With monitoring such as tracheal pressure recordings, the
eﬀort associated with attempts to breathe during airway occlusion are

5
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Fig. 2. Impact of oxygen exposure on times to respiratory arrest in a rat model of complete airway occlusion. Panel A: Rats exposed to room air (n = 8 rats)
experienced respiratory arrest about 50 s after the onset of controlled airway occlusion (a method to simulate laryngospasm-based complete airway closure). By
contrast, rats breathing for 5 min in an oxygen enriched atmosphere before airway occlusion lasted nearly twice as long before respiratory arrest occurred (n = 12
rats). P value is after correction for multiple comparisons (see Panel E). Panel B: Each attempted breath and its associated inspiratory force are plotted. Animals
breathing air are shown in red and animals breathing oxygen are shown in blue. The large increases in inspiratory eﬀort just before respiratory arrest are seen near
the mean times for respiratory arrest (vertical red and blue lines). Because large inspiratory eﬀort against a closed airway is biophysically favorable for the generation
of pulmonary edema, the persistence of smaller inspiratory breath attempts protects longer against the development of pulmonary edema. Panel C: Oxygen shifts the
desaturation proﬁle to later times. There is nearly a 40 s delay in desaturation onset in animals breathing oxygen vs. those breathing air. This delay in the onset of
desaturation and the time for respiratory arrest is the basis of the protection against death. The gray horizontal lines indicate the intersection of the linear regression
line with the mean time to respiratory arrest. Linear regression lines are ﬁtted only to the falling phase of the oxygen saturation curves and are meant for comparison
of the rates of desaturation. They are not meant to summarize the entire multi-phasic saturation proﬁle. Panel D: The total number of breath attempts made during
complete airway closure is signiﬁcantly greater in animals that breathed oxygen prior to airway occlusion. This is another representation of the protective role of
oxygen. P value is after correction for multiple comparisons (see Panel E). Panel E: comparison of briefer oxygen exposure times and lower concentrations of oxygen
on the times to respiratory arrest. Brief (30 s; n = 10 rats) exposure to oxygen is as protective as longer (5 min; n = 12 rats) exposures. Brief exposure to 50% oxygen
(n = 8 rats) did not retain statistical signiﬁcance when compared to air after post hoc correction for multiple comparisons (because the group sizes were small), but in
a straight t-test comparing only air and 50% oxygen the time to respiratory arrest was prolonged (p = .0135). Mean times were: 53.6 (air), 66.4 (brief 50% O2), 81.6
(brief O2), and 88.4 (oxygen) seconds. Illustrated p values are after correction for multiple comparisons after one-way analysis of variance (see text for additional
details). Panel F: Breath attempts for all oxygen conditions showing the impact of brief and 50% oxygen. (For interpretation of the references to colour in this ﬁgure
legend, the reader is referred to the web version of this article.)

pressure. In fact, in DBA/1 mice, there was no evidence of an eﬀect of
SSRI treatment on ventilation, but they did show that respiratory arrest
did not occur in treated animals in association with seizure activity
(Zeng et al., 2015). That the impact on respiratory arrest was consistent
in both models suggests that this action of SSRI treatment is not dependent on the change in respiratory rate that we observed or that Zeng
et al. did not observe.
The doses of selective serotonergic reuptake inhibitors used in this
model and in the mouse models are, however, medically impractical
(roughly ten times the clinical doses used for depression). More signiﬁcantly, their use may permit respiratory arrest at lower overall
oxygen saturations, which can make resuscitation more diﬃcult.

or electrical recordings that include both convulsive and inspiratory
EMG. Plethysmography can oﬀer clues based on the transitions into or
out of apneic episodes (Villiere et al., 2017). If one considers the point
of respiratory arrest as the onset of a form of central apnea (which we
do), the same masking challenges exist. The advantage of the current
study is that we were able to directly determine the point of respiratory
arrest before and after speciﬁc manipulations that have been shown to
prevent death.
6. Relation of our oxygen ﬁndings to those in mice
Suﬃcient access to oxygen is the one manipulation that has been
shown to protect absolutely against death in any animal model of
sudden death. That oxygen nearly doubled the time to respiratory arrest
is not surprising given other experiences with oxygen, e.g. breath
holding (Godfrey and Campbell, 1968; Godfrey and Campbell, 1969).
As we discussed previously (Nakase et al., 2016), breathing oxygen
prior to a breath holding dive prolonged the dive time by nearly twofold. In our own experience, oxygen does not alter seizure durations and
we are unaware of any evidence in any model where oxygen does alter
seizure durations. Oxygen exposure shifted the desaturation curve to
longer times, but once desaturation started, it followed a time course
that resembled that for air breathing animals (Figs. 1 and 2C). The
safety factor provided by oxygen with regard to the time to respiratory
arrest completely explains why oxygen treatment ensures survival of
100% of animals (Venit et al., 2004; Willott and Henry, 1976).

8. Hypoxia as cause or consequence of apnea
The mechanisms that have been proposed to account for death in
the same mouse models that can be protected with oxygen exposure or
SSRIs generally point to brainstem dysfunction, particularly involving
serotonergic respiratory brainstem neurons, caused by seizure activity
(e.g. spreading depolarization (Aiba and Noebels, 2015)). This dysfunction manifests as central apnea, which drives desaturation and
progresses to respiratory arrest. The protection aﬀorded by SSRI or
serotonergic receptor agonist pre-treatment has been viewed in the
context of this mechanism as protective against the possibility of central
apnea.
As described in the Introduction, our view has been that seizures
“disrupt” brainstem activity by activating brainstem regions, rather
than inactivating them. In our view, seizure activity drives laryngospasm and thus obstructive apnea. The obstructive apnea persists
as long as the laryngospasm persists, establishing a temporal competition for whether the seizure terminates before respiratory arrest or vice
versa. In this view, the central form of apnea (i.e. respiratory arrest) is a
consequence of hypoxia, not its initial cause.
Survival of audiogenic seizure-prone mice after exposure to oxygen
is diﬃcult to account for in the ﬁrst view (seizure-associated central
apnea), but readily accounted for in the second (seizure-associated
obstructive apnea). If oxygen exposure prevents death by preventing
the brainstem dysfunction and central apnea of the ﬁrst viewpoint, then
it is unclear what brainstem consequences are directly due to seizure
activity. In our view, all of the seizure-driven events (including laryngospasm and obstructive apnea) still occur, with or without an
oxygen-enriched atmosphere, but the temporal competition between
seizure termination and respiratory arrest is eliminated because of the
much longer times to respiratory arrest.
Whereas oxygen exposure increased both the number of breath attempts during occlusion (Fig. 2 D, F) and the time to respiratory arrest

7. Relation of our SSRI ﬁndings to those in mice
We found that systemic ﬂuoxetine (25 mg/kg given 1 h prior to
airway occlusion) signiﬁcantly prolonged the time to respiratory arrest
in a measure that was free from additional eﬀects of the drug such as
reducing the severity of seizure activity (Buchanan et al., 2014). More
pronounced was ﬂuoxetine's action to decrease the pre-occlusion respiratory rate, which is an indication of its actions on respiration referred to in the Introduction. Whereas the percent change in breath
attempt frequency caused by airway occlusion was equivalent in
ﬂuoxetine-treated or saline control animals (Fig. 3F), the absolute frequency of breath attempts was lower in ﬂuoxetine-treated animals
(Fig. 3E). The lower frequency is consistent with the slightly slower rate
of oxygen desaturation (not statistically signiﬁcant; Fig. 3C). Fluoxetine
may also have led to a signiﬁcant or subtle hyperventilation eﬀect to
prolong the time to respiratory arrest similar to what has been described for breath holding, but we have no direct evidence of hyperventilation (Godfrey and Campbell, 1968; Marks et al., 1997). We
did not measure tidal volume in animals together with tracheal
6
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Fig. 3. Impact of systemic ﬂuoxetine on times to respiratory arrest in a rat model of complete airway occlusion. Panels A-D resemble those shown in Fig. 2. Panel A:
Rats exposed to systemic ﬂuoxetine (25 mg/kg IP; n = 8 rats) experienced respiratory arrest at an average time after occlusion onset of 63.8 s. Saline injected control
rats (n = 8) arrested at an average time of 49.8 s after occlusion onset (p = .031). Panel B: There were no apparent diﬀerences in the inspiratory forces generated
during breath attempts while occluded (the mean times to respiratory arrest are shown as vertical orange and blue lines). Panel C: The slopes of the linear regression
lines did not diﬀer statistically. The gray horizontal lines indicate the intersection of the linear regression line with the mean time to respiratory arrest. Panel D: There
was no diﬀerence in the number of breath attempts between the two groups, but the increased time to respiratory arrest for the ﬂuoxetine group indicated that the
rate of breath attempts was reduced with the drug. Panel E: Frequency of breath attempts pre-injection with ﬂuoxetine or saline, post-injection (i.e. pre-occlusion),
and during occlusion are compared. There was no diﬀerence between saline and ﬂuoxetine groups in the pre-injection measures, but these groups diﬀered from each
other at later times (pre-occlusion p < .0001, occlusion p = .0241). P values shown on the graph are from a two-way ANOVA with repeated measures after Tukey's
multiple comparison test to correct for multiple comparisons. Other details are in the text. Panel F: The largest diﬀerential in respiratory (or respiratory attempts) rate
was between baseline and drug or saline. Fluoxetine showed a much larger eﬀect on the spontaneous breathing rate (p < .0001). The diﬀerential rate between preocclusion and occlusion was comparable for ﬂuoxetine and saline treated animals. (For interpretation of the references to colour in this ﬁgure legend, the reader is
referred to the web version of this article.)

(Fig. 2E), the increased time to respiratory arrest after ﬂuoxetine
treatment (Fig. 3A) was not associated with an increased number of
breath attempts (Fig. 3D). The frequency of breath attempts made by
ﬂuoxetine-treated animals was less than that by saline-treated animals
before and after airway occlusion (Fig. 3 E, F). As the contributions of
muscular eﬀort (forces generated during breath attempts and/or the
number of breath attempts) are associated with the rate of oxygen desaturation, a lower respiratory rate would be expected to be associated
with a longer time to respiratory arrest and protection from seizureassociated obstructive apnea. Whereas our study eliminates the complication of SSRI impact on seizure intensity, it does not address the
possibility of SSRI impact on the intensity of laryngospasm as a cause of
airway occlusion. Our study also does not permit us to address the
potential SSRI impact on seizure-associated central apnea, a phenomenon that we have also argued is due to brainstem activity (activation of
the diving reﬂex; Villiere et al., 2017).
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9. Translation to SUDEP prevention in epilepsy patients
We speculate that the remarkable protections against death that
have been demonstrated by Willott et al. (Willott and Henry, 1976) and
Venit et al. (Venit et al., 2004) can be translated into practical protections for epilepsy patients. Relatively brief access to an oxygen atmosphere just prior to airway occlusion led to a signiﬁcant prolongation of the time to respiratory arrest. Our data indicate that as little as
30 s of oxygen immediately prior to airway closure can cause enough of
an extension of the time to respiratory arrest that it would improve
survival odds if seizure activity caused obstructive apnea. Thirty seconds would be within the time window of a seizure itself, suggesting
that oxygen could be protective even if supplied after a seizure starts.
Fitting epilepsy patients for use in bed with either nasal cannula for
oxygen delivery alone or a continuous positive airway pressure (CPAP)
mask which provides oxygen plus provides pressure to prevent obstructive sleep apnea could prevent SUDEP (CPAP has even been suggested to reduce seizure frequency (Devinsky et al., 1994)).
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